Juvederm VOLUX - Synthetic-fluid tissue reconstructive material, anaesthetic
Access comprehensive regulatory information for Juvederm VOLUX - Synthetic-fluid tissue reconstructive material, anaesthetic in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Abbvie Pty Ltd, manufactured by Allergan in France. The device registration started on December 10, 2019.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
Juvéderm® VOLUX™ is an injectable implant intended to restore and create volume of the face. The presence of lidocaine is meant to reduce the patient’s pain during treatment.